⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANAB News
AnaptysBio, Inc. Common Stock
Form 8-K/A
sec.gov
ANABV
ANAB
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
globenewswire.com
ANAB
Form 8-K
sec.gov
ANAB
ANABV
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
globenewswire.com
TRAX
ANAB
Form 8-K
sec.gov
ANAB
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
globenewswire.com
ANAB
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
globenewswire.com
TRAX
ANAB
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
globenewswire.com
ANAB
Form 8-K
sec.gov
ANAB
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
ANAB
VNDA